So-Young (SY) Q2 2025 Earnings Call Transcript
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 15 2025
0mins
Should l Buy SY?
Source: NASDAQ.COM
- Author's Perspective: The opinions shared in the article are solely those of the author and do not represent Nasdaq, Inc.
- Data Limitations: The information is based on data available up to October 2023.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SY
About SY
So-Young International Inc is a holding company mainly engaged in online platform for discovering, evaluating and reserving medical aesthetic services. The Company operates its businesses through two segments including So-Young segment and Wuhan Miracle segment. So-Young segment mainly provides information services, reservation services, aesthetic treatment services and sales of medical products and maintenance services. Wuhan Miracle segment is mainly engaged in the research and development, production, sales and agency of laser and other optoelectronic medical equipment. The Company operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Significant Revenue Growth: So-Young International reported a GAAP EPS of -$0.15 for Q4, with revenues reaching $65.88 million, representing a 24.8% year-over-year increase, indicating strong market performance and growth potential.
- Surge in Aesthetic Services Revenue: Aesthetic treatment services revenue soared to RMB 248.1 million (approximately $35.5 million), a substantial increase from RMB 81.3 million in the same period of 2024, exceeding the high end of guidance and reflecting rising consumer demand for beauty services.
- Increased User Engagement: The number of verified treatment visits to branded aesthetic centers surpassed 125,000, compared to approximately 45,000 in the same period of 2024, demonstrating a significant boost in user engagement and enhancing brand loyalty.
- Optimistic Future Outlook: So-Young expects Q1 2026 aesthetic treatment services revenues to be between RMB 268.0 million (approximately $38.3 million) and RMB 278.0 million (approximately $39.8 million), representing a 171.2% to 181.3% increase from the same period in 2025, reflecting strong confidence in future growth.
See More
- Earnings Call Scheduled: So-Young International Inc. will host a conference call on March 25, 2026, at 7:30 AM ET to discuss its Q4 2025 earnings results, aiming to provide investors with the latest financial insights and company developments.
- Live Webcast Access: Investors can access the live webcast by visiting https://ir.soyoung.com, ensuring they receive real-time updates on the company's financial data and management perspectives, thereby enhancing transparency and investor confidence.
- Dial-in Participation: Participants can join the call by dialing +1-888-346-8982 for the US or +1-412-902-4272 for international access, using the passcode “So Young International Inc.” to ensure smooth entry into the meeting and timely information dissemination.
- Replay Information Provided: After the call, investors can listen to the replay by dialing +1-855-669-9658 for the US or +1-412-317-0088 for international access, using the passcode “5232304,” ensuring that those unable to participate live can still access critical information.
See More
- Significant Revenue Growth: In Q4 2025, total revenues reached RMB 460.7 million (approximately $65.9 million), marking a 24.8% increase from RMB 369.2 million in the same period of 2024, primarily driven by the expansion of branded aesthetic centers, indicating strong growth momentum in the market.
- Rising Cost Pressure: The cost of revenues for Q4 was RMB 255.9 million (approximately $36.6 million), a 67.2% increase year-over-year, reflecting the operational cost increases associated with the expansion of branded aesthetic centers, which may pose challenges to future profit margins.
- Significant Reduction in Operating Expenses: Total operating expenses for Q4 were RMB 327.7 million (approximately $46.9 million), down 59.8% from RMB 815.2 million in Q4 2024, indicating substantial success in cost control, which helps improve the overall financial condition.
- Optimistic Future Outlook: So-Young expects Q1 2026 aesthetic treatment service revenues to be between RMB 268.0 million and RMB 278.0 million (approximately $38.3 million to $39.8 million), representing a 171.2% to 181.3% increase from the same period in 2025, reflecting the company's confidence in market demand and potential for sustained growth.
See More
- Financial Performance: Soyoung International reported a revenue of $460.72 million for the fourth quarter.
- Market Impact: The revenue figures indicate a significant performance in the market, reflecting the company's growth and stability.
See More
- Financial Overview: The report indicates a gross profit of 204.774 million for the specified period.
- Company Performance: The financial results reflect the company's performance in the international market.
See More








